January 19, 2017 12:54 AM ET


Company Overview of Marinus Pharmaceuticals, Inc.

Key Executives for Marinus Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Christopher Michael Cashman 65 RelationshipsExecutive Chairman, Chief Executive Officer and President59
Edward F. Smith No RelationshipsChief Financial Officer, Vice President, Treasurer and Secretary45
Kimberly A. McCormick PharmDNo RelationshipsHead of Regulatory Affairs--
Albena Patroneva M.D.No RelationshipsChief Medical Officer51

Marinus Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Christopher Michael Cashman 65 RelationshipsMarinus Pharmaceuticals, Inc.59
Nicole Vitullo M.B.A. 52 RelationshipsDomain Associates, L.L.C.59
Timothy M. Mayleben 60 RelationshipsEsperion Therapeutics, Inc.55
Jay P. Shepard 36 RelationshipsVersartis, Inc.58
Enrique J. Carrazana M.D. 5 RelationshipsAcorda Therapeutics, Inc.54
View All Board Members

Marinus Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Timothy M. Mayleben60 Relationships3 Executives
Compensation Committee Jay P. Shepard36 Relationships2 Executives
Nominating Committee M.B.A.Nicole Vitullo52 Relationships3 Executives
Corporate Governance Committee M.B.A.Nicole Vitullo52 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Not meaningful
Total Value of Options$651.8K
Compensation as of Fiscal Year 2015
Marinus Pharmaceuticals, Inc. CEO Compensation
Industry Average


iAnthus Capital Holdings, Inc. Appoints Russell Shepard to the Advisory Board
January 18, 2017 1:18 AM ET
Mayuran Sriskandarajah to Resign from VIVUS, Inc.'s Board of Directors
January 17, 2017 9:06 PM ET
Bayer Appoints Dr. Carsten Brunn as President of its Pharmaceuticals Business in Americas
January 17, 2017 2:00 PM ET
Tetra Discovery Partners Appoints Richard M. Erwin as Vice President, Clinical Operations
January 17, 2017 1:30 PM ET
ANI Pharmaceuticals, Inc. Announces Appointment of Karen Quinn as Vice President Corticotropin Regulatory Affairs
January 17, 2017 1:30 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Marinus Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.